49 related articles for article (PubMed ID: 92880)
1. The isolation of leukokinin-H and leukokininogen from human ascites fluid; their properties and role.
Greenbaum LM; Semente G; Grebow P; Roffman S
Adv Exp Med Biol; 1979; 120B():205-14. PubMed ID: 92880
[TBL] [Abstract][Full Text] [Related]
2. Pepstatin, an inhibitor of leukokinin formation and ascitic fluid accumulation.
Greenbaum LM; Grebow P; Johnston M; Prakash A; Semente G
Cancer Res; 1975 Mar; 35(3):706-10. PubMed ID: 46779
[TBL] [Abstract][Full Text] [Related]
3. Pepstatin, an inhibitor of acid kininogenases and ascites retardant in neoplastic disease.
Greenbaum LM
Fed Proc; 1979 Dec; 38(13):2788-91. PubMed ID: 92421
[TBL] [Abstract][Full Text] [Related]
4. Leukokinin-H generated from human ascites fluid; its isolation and pharmacology.
Grebow P; Prakash A; Greenbaum LM
Agents Actions; 1979 Aug; 9(3):265-74. PubMed ID: 91314
[No Abstract] [Full Text] [Related]
5. Properties of leukokininogen isolated from human neoplastic ascites.
Roffman S; Greenbaum LM
Biochem Pharmacol; 1979 Apr; 28(7):1043-50. PubMed ID: 87196
[No Abstract] [Full Text] [Related]
6. Leukokinins; their pharmacological properties and role in the pathology of fluid (ascites) accumulation.
Greenbaum LM; Semente G; Prakash A; Roffman S
Agents Actions; 1978 Jan; 8(1-2):80-4. PubMed ID: 76439
[No Abstract] [Full Text] [Related]
7. Pepstatin inhibition of cathepsin D in situ and its modification of leukokinin formation: HPLC separation of fluorescamine-treated kinins.
Greenbaum LM; Sutherland JH; Narayan TK
Adv Exp Med Biol; 1983; 156 (Pt B)():783-7. PubMed ID: 6190383
[No Abstract] [Full Text] [Related]
8. Effects of protizinic acid on leukokinin generation and its physiological action.
Suzuki K; Niho T; Yamaguchi K; Ohnishi H
Agents Actions; 1984 Jun; 14(5-6):699-706. PubMed ID: 6475667
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the contractile action of bradykinin on isolated smooth muscle preparations by derivatives of low molecular weight peptides.
Claeson G; Fareed J; Larsson C; Kindel G; Arielly S; Simonsson R; Messmore HL; Balis JU
Adv Exp Med Biol; 1979; 120B():691-713. PubMed ID: 517262
[TBL] [Abstract][Full Text] [Related]
10. Studies on leukokinins. II. Studies on the formation, partial amino acid sequence and chemical properties of leukokinins M and PMN.
Chang J; Freer R; Stella R; Greenbaum LM
Biochem Pharmacol; 1972 Dec; 21(23):3095-106. PubMed ID: 4650632
[No Abstract] [Full Text] [Related]
11. Potentiation of bradykinin by a factor present in the salivary gland of the rat.
Santos RA; Cunha Melo JR; Heneine IF; Lauar NS; Beraldo WT
Adv Exp Med Biol; 1979; 120B():581-7. PubMed ID: 517253
[No Abstract] [Full Text] [Related]
12. Bradykinin receptor antagonists containing N-substituted amino acids: in vitro and in vivo B(2) and B(1) receptor antagonist activity.
Goodfellow VS; Marathe MV; Kuhlman KG; Fitzpatrick TD; Cuadrado D; Hanson W; Zuzack JS; Ross SE; Wieczorek M; Burkard M; Whalley ET
J Med Chem; 1996 Mar; 39(7):1472-84. PubMed ID: 8691478
[TBL] [Abstract][Full Text] [Related]
13. Complex effects of antibodies to polypeptide hormones.
Goodfriend TL; Webster ME; McGuire JS
J Clin Endocrinol Metab; 1970 May; 30(5):565-72. PubMed ID: 4192201
[No Abstract] [Full Text] [Related]
14. Plasma kinin formation by complexes of aggregated gamma-globulin and serum proteins.
Eisen V; Smith HG
Br J Exp Pathol; 1970 Jun; 51(3):328-31. PubMed ID: 4193678
[TBL] [Abstract][Full Text] [Related]
15. Effect of stretching of the guinea-pig ileum upon its response to bradykinin and to bradykinin-potentiating peptides.
Shimuta SI; Sabia EB; Paiva AC; Paiva TB
Adv Biosci; 1978 Jul; 17():231-6. PubMed ID: 755698
[No Abstract] [Full Text] [Related]
16. Effects of 'casoparan', a peptide isolated from casein hydrolysates with mastoparan-like properties.
Lebrun I; Cavallaro V; Juliano L; Juliano MA; de Sousa e Silva MC
Mediators Inflamm; 2004 Aug; 13(4):263-8. PubMed ID: 15545057
[TBL] [Abstract][Full Text] [Related]
17. [The influence of calcium ion antagonists on the effects of bradykinin].
Shvarts GIa; Rumiantsev EA; Siubaev RD; Faermark IF
Farmakol Toksikol; 1991; 54(2):40-3. PubMed ID: 1884794
[TBL] [Abstract][Full Text] [Related]
18. The leukokinin system; its role in fluid accumulation in malignancy and inflammation.
Greenbaum LM; Prakash A; Semente G; Johnston M
Agents Actions; 1973 Dec; 3(5):332-4. PubMed ID: 4131798
[No Abstract] [Full Text] [Related]
19. [Connection between structure and biological activity of new bradykinin analogs].
Reissmann S; Paegelow I; Arold H
Acta Biol Med Ger; 1974; 33(1):77-88. PubMed ID: 4422324
[No Abstract] [Full Text] [Related]
20. A study of some bradykinin potentiating peptides derived from plasma proteins.
Faber DB; Van der Meer C
Arch Int Pharmacodyn Ther; 1973 Oct; 205(2):226-43. PubMed ID: 4358297
[No Abstract] [Full Text] [Related]
[Next] [New Search]
